|
Delayed
Nasdaq
04:00:00 24/06/2026 HKT
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.39B 5.07B 4.63B 8.67B 592B 8.69B 59.95B 23.26B 304B 23.53B 23.02B 978B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.24B 4.93B 4.5B 8.43B 575B 8.45B 58.27B 22.61B 295B 22.87B 22.37B 950B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +1.63% | ||
| 6 months | +54.58% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.68 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/6/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 1/5/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 26/3/26 | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +154.56% | +427.34% | 6.27B | |
| -2.54% | -2.84% | -1.90% | +14.52% | 50.35B | |
| -0.97% | +0.85% | +438.25% | +522.29% | 45.2B | |
| -1.59% | +2.35% | +45.53% | +21.28% | 44.71B | |
| -1.07% | -2.11% | +12.63% | +75.25% | 41.24B | |
| +0.53% | -1.67% | +15.16% | +49.88% | 33.08B | |
| -0.46% | +8.43% | - | - | 17.81B | |
| -0.13% | -1.38% | +22.81% | +123.45% | 16.56B | |
| -1.01% | +0.50% | +15.83% | +27.98% | 14.82B | |
| -1.42% | -0.95% | +77.89% | +41.34% | 14B | |
| Average | -0.80% | +0.20% | +86.75% | +144.81% | 28.4B | |
| Weighted average by Cap. | -1.12% | -0.41% | +95.57% | +134.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 12.91 12.14 11.09 20.75 1.42K 20.81 143.5 55.69 726.63 56.33 55.1 2.34K |
| Net income | -236M -203M -191M -174M -326M -22.26B -327M -2.26B -875M -11.42B -885M -866M -36.79B | -198M -170M -160M -146M -273M -18.65B -274M -1.89B -733M -9.57B -742M -726M -30.83B |
| Net Debt | -364M -314M -295M -269M -504M -34.4B -505M -3.49B -1.35B -17.65B -1.37B -1.34B -56.86B | -176M -152M -143M -130M -244M -16.64B -244M -1.69B -654M -8.54B -662M -647M -27.5B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
